Capital World Investors
ALXO icon

Capital World Investors’s ALX Oncology ALXO Stock Holding History

Capital World Investors’s Portfolio ALXO Stock Details ALXO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-300,000
Closed -$11.3M – 568
2020
Q3 		$11.3M Buy
+300,000
New +$11.8M ﹤0.01% 502

Other funds holding ALXO

VP
venBio Partners San Francisco, California $281M AUM 261.03% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BOTOTLSJU
Board of Trustees of The Leland Stanford Junior University Redwood City, California $849M AUM 55.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
FCMI
Foresite Capital Management IV Larkspur, California $237M AUM 107.53% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

Capital World Investors's ALXO Position: Q4 2020 in Review

Capital World Investors sold out of ALX Oncology (ALXO) in Q4 2020, closing a stake of 300,000 shares — an estimated $11.3M sold.

Capital World Investors first reported a position in ALXO in Q3 2020 and held it in 1 quarter. The position peaked at $11.3M in Q3 2020. 89 funds tracked by Wall St. Rank hold ALXO as of Q4 2020.

  • Capital World Investors reported no remaining ALX Oncology position as of Q4 2020 after selling out during the quarter.
  • Capital World Investors sold 300,000 ALX Oncology shares in Q4 2020, an estimated $11.3M.
  • Capital World Investors first reported a position in ALX Oncology in Q3 2020 and held it in 1 quarter.
  • Capital World Investors's ALX Oncology position peaked at $11.3M in Q3 2020.
  • 89 funds tracked by Wall St. Rank held ALX Oncology as of Q4 2020.

Based on Capital World Investors's 13F filing for Q4 2020, filed 12 Feb 2021.